Short interest in ARS Pharmaceuticals Inc (NASDAQ:SPRY) increased during the last reporting period, rising from 11.10M to 11.92M. This put 23.16% of the company's publicly available shares short.

How do I know I can trust these reviews about Amazon.com? How do I know I can trust these reviews about Amazon.com? 4,552,666 reviews on ConsumerAffairs are verified. We require contact ...